NCT06507462View on ClinicalTrials.gov

A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3

CompletedOBSERVATIONAL
Enrollment

460

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Prostate Cancer
Interventions
PROCEDURE

prostate biopsy

All patients were required to underwent transperineal prostate biopsy and have corresponding pathological diagnosis results.

Trial Locations (3)

230001

Department of Urology, The First Affiliated Hospital of USTC, Hefei

233000

Department of Urology, The First Affiliated Hospital of Bengbu Medical University, Bengbu

241000

Department of Urology, The First Affiliated Hospital of Wannan Medical College, Wuhu

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV

NCT06507462 - A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3 | Biotech Hunter | Biotech Hunter